Clinical course, prognostic factors, and outcome prediction for HIV patients in the ICU - The PIP (Pulmonary complications, ICU support, and prognostic factors in hospitalized patients with HIV) study

被引:73
作者
Afessa, B [1 ]
Green, B [1 ]
机构
[1] Univ Florida, Hlth Sci Ctr, Dept Internal Med, Div Pulm & Crit Care, Jacksonville, FL 32209 USA
关键词
AIDS; APACHE; ARDS; HIV; ICU admission; organ failure; outcome; Pneumocystis carinii pneumonia; respiratory failure; systemic inflammatory response syndrome;
D O I
10.1378/chest.118.1.138
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Study objective: To describe the clinical course and prognostic factors in patients with HIV admitted to the ICU. Design: Prospective, observational. Setting: A university-affiliated medical center. Methods: We included 169 consecutive ICU admissions, from April 1995 through March 1999, of 141 adults with HIV. Data collected included APACHE (acute physiology and chronic health evaluation) II score, CD4(+) lymphocyte count, serum albumin level, in-hospital mortality, and die development of organ failure, systemic inflammatory response syndrome (SIRS), and ARDS. Results: The ICU admission rate of hospitalized patients with HIV infection was 12%. The mast common reason for ICU admission was respiratory failure, occurring in 65 patient admissions. Mechanical ventilation was required in 91 admissions (54%), ARDS developed in 37 admissions (22%), Pneumocystis carinii pneumonia was diagnosed in 24 admissions (14%), and SIRS developed in 126 admissions (75%). One or more organ failures developed in 131 admissions (78%). The actual and predicted mortality rates were 29.6% and 45.2%, respectively, with a standardized mortality ratio of 0.65. The most frequent immediate cause of death was bacterial infection. The CD4+ lymphocyte count (median, 27.5 cells/mu L vs 59 cells/mu L; p = 0.0310) and serum albumin level (median 2.2 g/dL vs 2.6 g/dL; p = 0.0355) of nonsurvivors were lower and the APACHE II score (median, 30 vs 21; p < 0.0001) was higher, compared to those of survivors. A higher APACHE II score (odds ratio [OR], 1.11; 95% confidence interval [CI], 1.05 to 1.16) and a transfer from another hospital ward (OR, 3.03; 95% CI, 1.20 to 7.68) were independently associated with increased mortality. The median number of organ failures that developed in survivors was one, compared to four in nonsurvivors (p < 0.0001). Conclusions: The outcome of HIV-infected patients admitted to the ICU has improved over the years. The CD4 count does not correlate with in-hospital mortality. Higher APACHE II scores and a transfer from another hospital ward are associated with a poor outcome.
引用
收藏
页码:138 / 145
页数:8
相关论文
共 38 条
[1]   EARLY PREDICTORS OF OUTCOME FOR HIV PATIENTS WITH NEUROLOGICAL FAILURE [J].
BEDOS, JP ;
CHASTANG, C ;
LUCET, JC ;
KALO, T ;
GACHOT, B ;
WOLFF, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (01) :35-40
[2]   US hospital care for HIV-infected persons and the role of public, private, and veterans administration hospitals [J].
Bennett, CL ;
Curtis, JR ;
Achenbach, C ;
Arno, P ;
Bennett, R ;
Fahs, MC ;
Horner, RD ;
ShawTaylor, Y ;
Andrulis, D .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1996, 13 (05) :416-421
[3]   THE AMERICAN-EUROPEAN CONSENSUS CONFERENCE ON ARDS - DEFINITIONS, MECHANISMS, RELEVANT OUTCOMES, AND CLINICAL-TRIAL COORDINATION [J].
BERNARD, GR ;
ARTIGAS, A ;
BRIGHAM, KL ;
CARLET, J ;
FALKE, K ;
HUDSON, L ;
LAMY, M ;
LEGALL, JR ;
MORRIS, A ;
SPRAGG, R ;
COCHIN, B ;
LANKEN, PN ;
LEEPER, KV ;
MARINI, J ;
MURRAY, JF ;
OPPENHEIMER, L ;
PESENTI, A ;
REID, L ;
RINALDO, J ;
VILLAR, J ;
VANASBECK, BS ;
DHAINAUT, JF ;
MANCEBO, J ;
MATTHAY, M ;
MEYRICK, B ;
PAYEN, D ;
PERRET, C ;
FOWLER, AA ;
SCHALLER, MD ;
HUDSON, LD ;
HYERS, T ;
KNAUS, W ;
MATTHAY, R ;
PINSKY, M ;
BONE, RC ;
BOSKEN, C ;
JOHANSON, WG ;
LEWANDOWSKI, K ;
REPINE, J ;
RODRIGUEZROISIN, R ;
ROUSSOS, C ;
ANTONELLI, MA ;
BELOUCIF, S ;
BIHARI, D ;
BURCHARDI, H ;
LEMAIRE, F ;
MONTRAVERS, P ;
PETTY, TL ;
ROBOTHAM, J ;
ZAPOL, W .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (03) :818-824
[4]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[5]   LENGTH OF STAY AND SURVIVAL AFTER INTENSIVE-CARE FOR SEVERE PNEUMOCYSTIS-CARINII PNEUMONIA - A PROSPECTIVE-STUDY [J].
BOZZETTE, SA ;
FEIGAL, D ;
CHIU, J ;
GLUCKSTEIN, D ;
KEMPER, C ;
SATTLER, F .
CHEST, 1992, 101 (05) :1404-1407
[6]   The care of HIV-infected adults in the United States [J].
Bozzette, SA ;
Berry, SH ;
Duan, NJ ;
Frankel, MR ;
Leibowitz, AA ;
Lefkowitz, D ;
Emmons, CA ;
Senterfitt, JW ;
Berk, ML ;
Morton, SC ;
Shapiro, MF .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (26) :1897-1904
[7]   ETHICAL CONSIDERATIONS IN THE TREATMENT OF AIDS PATIENTS IN THE INTENSIVE-CARE UNIT [J].
BROWN, J ;
SPRUNG, CL .
CRITICAL CARE CLINICS, 1993, 9 (01) :115-123
[8]   PREDICTIVE ABILITY OF ACUTE PHYSIOLOGY AND CHRONIC HEALTH EVALUATION-II SCORING APPLIED TO HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE PATIENTS [J].
BROWN, MC ;
CREDE, WB .
CRITICAL CARE MEDICINE, 1995, 23 (05) :848-853
[9]   Predictors of short- and long-term survival in HIV-infected patients admitted to the ICU [J].
Casalino, E ;
Mendoza-Sassi, G ;
Wolff, M ;
Bédos, JP ;
Gaudebout, C ;
Regnier, B ;
Vachon, F .
CHEST, 1998, 113 (02) :421-429
[10]   PREDICTING SURVIVAL IN AIDS PATIENTS WITH RESPIRATORY-FAILURE - APPLICATION OF THE APACHE-II SCORING SYSTEM [J].
CHU, DY .
CRITICAL CARE CLINICS, 1993, 9 (01) :89-105